Skip to main content

Table 1 Baseline demographics and disease characteristics; PSOLAR psoriasis patients

From: Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry

 

Psoriasis patients self-reporting PsA, established by a HCPa

Psoriasis patients self-reporting PsAb

Patients with psoriasis onlyc

All PSOLAR patientsd

Patients enrolled, N

1719

4315

7775

12,090

Years since psoriasis diagnosis

 N

1707

4287

7692

11,979

 Mean ± SD

21.1 ± 13.3

19.7 ± 13.5

16.3 ± 13.3

17.5 ± 13.4

 Median

19.8

18.3

13.7

15.2

Age, years

 N

1719

4315

7774

12,089

 Mean ± SD

50.8 ± 12.1

50.4 ± 12.6

47.6 ± 14.5

48.6 ± 13.9

 Median

51.0

51.0

48.0

49.0

Sex, N

1719

4315

7775

12,090

 Men

894 (52.0)

2194 (50.8)

4441 (57.1)

6635 (54.9)

Race, N

1719

4315

7774

12,089

 White

1484 (86.3)

3622 (83.9)

6401 (82.3)

10,023 (82.9)

Weight, kg

 N

1682

4255

7663

11,918

 Mean ± SD

92.7 ± 22.9

92.2 ± 23.1

89.2 ± 22.6

90.2 ± 22.9

 Median

90.0

89.9

86.3

88.0

Body mass index (BMI), kg/m2

 N

1679

4248

7656

11,904

 Mean ± SD

31.9 ± 7.1

31.8 ± 7.3

30.4 ± 7.1

30.9 ± 7.2

 Median

30.84

30.68

29.21

29.71

Obesity class

1679

4248

7656

11,904

 Underweight (BMI < 18.5)

5 (0.3)

15 (0.4)

46 (0.6)

61 (0.5)

 Normal (18.5–24.9)

244 (14.5)

645 (15.2)

1631 (21.3)

2276 (19.1)

 Overweight (25.0–29.9)

501 (29.8)

1296 (30.5)

2536 (33.1)

3832 (32.2)

 Obesity class I (30.0–34.9)

438 (26.1)

1094 (25.8)

1808 (23.6)

2902 (24.4)

 Obesity class II (35.0–39.9)

265 (15.8)

654 (15.4)

906 (11.8)

1560 (13.1)

 Obesity class III (40.0 +)

226 (13.5)

544 (12.8)

729 (9.5)

1273 (10.7)

  1. Values are presented as n (%) unless noted otherwise
  2. HCP healthcare provider, PsA psoriatic arthritis, SD standard deviation
  3. aA subset of PSOLAR psoriasis patients self-reporting PsA, established by a HCP
  4. bPSOLAR psoriasis patients with self-reported PsA
  5. cPSOLAR psoriasis patients not self-reporting PsA
  6. dIncludes all PSOLAR patients with psoriasis who may or may not have PsA